Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Blood 94:703a, 1999
All of the ingredients used in IVs are manufactured or compounded in FDA-registered facilities under stringent quality control guidelines
Cardiovascular risk reduction
Liposomal Cytarabine and Daunorubicin (CPX-351) in Combination with Gemtuzumab Ozogamicin (GO) in Relapsed Refractory (R/R) Acute Myeloid Leukemia (AML) and Post-Hypomethylating Agent (Post-HMA) Failure High-Risk Myelodysplastic Syndrome (HR-MDS)
US$ 27.70
US$ 27.53
US$ 22.15
![Kikusui PAS60-18 Stabilized Power Supply [c1199505251] Hozan](https://cdn.shopify.com/s/files/1/0712/7370/9816/files/i-img1200x800-17573955698269tzu3tg11771.jpg?v=1757564934)
![Konica Minolta CC-100 CRT Convergence Meter [v1199400843] Daihen](https://cdn.shopify.com/s/files/1/0712/7370/9816/files/i-img1200x900-175730465659524hu3nr449.jpg?v=1757577401)
![ICOM IC-7100 HF VHF UHF Transceiver 100W [l1199393247] Ebara](https://cdn.shopify.com/s/files/1/0712/7370/9816/files/i-img1200x847-17573171118515t9sy9s9225.jpg?v=1757564909)